Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call Transcript
Operator: Greetings, and welcome to the Bausch Health's First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Bausch Health Companies Inc. (BHC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GoldenTree Asset Management Steven Tananbaum | 34,665,731 | $186,982,483 | 11.09% | |
| 2. | MFN Partners Farhad Nanji And Michael Demichele | 6,000,000 | $32,400,000 | 0.68% | |
| 3. | Hudson Bay Capital Management Sander Gerber | 5,000,000 | $27,000,000 | 0.09% | |
| 4. | Renaissance Technologies Jim Simons | 1,575,772 | $8,509,169 | +11% | 0.01% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,195,217 | $6,461,219 | -57% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.25 | 2,500,000 | $15,625,000.00 | 73,255,869 | 2025-11-25 | Filing | |
| $9.00 | 34,721,118 | $312,490,062.00 | 70,755,869 | 2025-08-14 | Filing | |
| $7.06 | 86,409 | $610,047.54 | 36,034,751 | 2025-08-13 | Filing | |
| $6.88 | 1,156,640 | $7,957,683.20 | 35,948,342 | 2025-08-12 | Filing | |
| $6.35 | 2,000,000 | $12,700,000.00 | 34,791,702 | 2025-08-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.77 | 4,420 | $25,503.40 | 616,761 | 2026-03-03 | Filing | |
| $5.78 | 6,856 | $39,627.68 | 776,076 | 2026-03-02 | Filing | |
| $5.95 | 8,388 | $49,908.60 | 809,258 | 2026-02-27 | Filing | |
| $7.31 | 13,370 | $97,734.70 | 499,585 | 2025-09-08 | Filing | |
| $7.66 | 15,912 | $121,885.92 | 73,795 | 2025-08-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,000,000 | $43,200,000 | 0.07% | |
| 2. | 7,403,759 | $40,024,721 | 0% | |
| 3. | 5,000,000 | $27,000,000 | 0.17% | |
| 4. | 3,798,957 | $20,470,892 | 0.01% | |
| 5. | 3,604,818 | $19,455,594 | 0% |
News See All
Billionaire Howard Marks' 10 Stock Picks with Huge Upside Potential
Howard Marks, the billionaire chief of Oaktree Capital Management, recently appeared on news platform CNBC to outline a measured perspective on the current state of private credit, market valuations, ...
7 Best Small-Cap Drug Manufacturing Stocks to Buy According to Hedge Funds
In this article, we will take a look at some of the small-cap drug manufacturing stocks that are highly favored by hedge funds.
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
TheFly reported on February 19 that Bank of America raised its price target for Bausch + Lomb (BLCO) to $15 from $13 and kept an Underperform rating.
7 Oversold Pharma Stocks to Buy Now
In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected to have grown to $883.97 billion.
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript February 18, 2026Bausch Health Companies Inc. misses on earnings expectations.
Bausch Health (BHC) Announces Global Phase 3 RED-C Clinical Program Results
Bausch Health Companies Inc. (NYSE:BHC) is one of the most undervalued Canadian stocks to buy according to hedge funds.
12 Most Undervalued Canadian Stocks to Buy According to Hedge Funds
On January 27, Sherry Paul, Morgan Stanley senior portfolio manager, joined CNBC's 'Closing Bell' to discuss whether more volatility is ahead.
Bausch Health Companies Inc. (BHC) Announces the Commercial Expansion of OraPharma into Canada and Puerto Rico
Bausch Health Companies Inc. (NYSE:BHC) is one of the best cheap stocks under $10 to buy now. Bausch Health Companies Inc.
13 Cheap Stocks Under $10 to Buy Now
On November 11, Ed Yardeni, Yardeni Research president, appeared on CNBC’s ‘Squawk on the Street’ to talk about the market outlooks and how earnings are driving the market.